Skip to main content


Aims and scope

Antimicrobial Resistance and Infection Control is a global forum for all those working on the prevention of healthcare associated infections, and of antimicrobial resistance development in both health-care settings and the community. The journal welcomes a broad spectrum of article types – including original research, reviews, guidelines, and commentaries – with the aim of promoting innovative and evidence-based practices in the field of infection control that reduce the burden of healthcare-associated infections and antimicrobial resistance.

Antimicrobial Resistance and Infection Control believes that future solutions require a better understanding of the factors contributing to the development and spread of multi-drug resistance pathogens, interventions to prevent transmission and infection, and insight into the difference between settings with limited, middle or high resources.

Antimicrobial Resistance and Infection Control combines best practices, experience and latest research results from around the globe to overcome the challenge posed by healthcare-associated infections. The journal welcomes manuscripts related to the epidemiology, surveillance, and prevention of healthcare infections and antimicrobial resistance.

The journal’s primary focus is on healthcare settings, but also considers community-based public health research relating to the prevention of antimicrobial resistance.

Manuscripts on the following are in scope:
• Prevention of healthcare-associated infection
• Infection control and antimicrobial resistance in high-risk settings (e.g. ICUs)
• Healthcare-associated infection prevention and antimicrobial resistance in special settings e.g. long-term care facilities
• Infection control and antimicrobial resistance in community and public healthcare settings
• Special considerations in infection control and antimicrobial resistance in resource-limited settings
• Antimicrobial stewardship interventions are within scope where they seek to reduce antimicrobial resistance or healthcare infections
• Surveillance of healthcare-associated infections and antimicrobial-resistant infections in healthcare and the community

Manuscripts on the following are not in scope:
• Single-point and single-center estimates of antimicrobial resistance rates, unless they illustrate new developments
• Antimicrobial resistance in animals or the environment, unless there are clear links to human health (One Health Principle)
• Studies focusing on the clinical diagnosis or treatment of infectious diseases
• Laboratory-based research and microbiological aspects of AMR without implications for clinical infection prevention

Society affiliations

ARIC is proud to be affiliated with several societies that support and promote the work done in our field.

The International Conference for Prevention and Infection Control (ICPIC) is a unique platform to foster knowledge sharing and exchange experiences for the prevention of healthcare-associated infection and the control of antimicrobial resistance among countries around the world. To achieve this aim and to ensure a global dialogue, ICPIC encourages and facilitates the attendance of many fellows from nations with limited resources, notably from the African region.

The Asia Pacific Society of Infection Control (APSIC) was established in 1998 and is a multi-national, voluntary organization dedicated to the advancement of infection control practice to reduce hospital associated infections, monitor and control emerging and re-emerging infectious diseases and improved patient outcomes. APSIC aims to bring together multidisciplinary infection control professionals in the region to share their knowledge, experience, skills, and quality improvement and research findings by facilitating the exchange of information through training courses, seminars, congresses and conferences in the Asia Pacific region.

The Infection Control Africa Network (ICAN) is an organization that promotes collaboration between individuals and institutions working in the field of infection control in Africa. The network currently has over 300 members from 24 African countries, and is led by an enthusiastic board of multi-national leaders in infection control. The vision of ICAN is an African continent where safe patient care is ensured for all through the implementation of strong infection control programs. ICAN has several active working groups dedicated to reducing healthcare associated infection and promoting antimicrobial stewardship on the continent, including education, communication, surveillance and community participation committees.

Open access

All articles published by Antimicrobial Resistance & Infection Control are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

As authors of articles published in Antimicrobial Resistance & Infection Control you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article processing charges (APC)

Authors who publish open access in Antimicrobial Resistance & Infection Control are required to pay an article processing charge (APC). The APC price will be determined from the date on which the article is accepted for publication.

The current APC, subject to VAT or local taxes where applicable, is: £2190.00/$3090.00/€2590.00

Visit our open access support portal and our Journal Pricing FAQs for further information.

Open access funding

Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.

Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.

Springer Nature offers APC waivers and discounts for articles published in our fully open access journals whose corresponding authors are based in the world’s lowest income countries (see our APC waivers and discounts policy for further information). Requests for APC waivers and discounts from other authors will be considered on a case-by-case basis, and may be granted in cases of financial need (see our open access policies for journals for more information). All applications for discretionary APC waivers and discounts should be made at the point of manuscript submission; requests made during the review process or after acceptance are unable to be considered.

Indexing services

All articles published in Antimicrobial Resistance & Infection Control are included in:

  • DOAJ
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • Scopus

The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Antimicrobial Resistance & Infection Control operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.

The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.

Expedited Peer Review

Antimicrobial Resistance & Infection Control  recognises that scientifically sound, high quality manuscripts are often turned away from broad-scope "high-impact" journals based on the issue of "general interest." The journal will consider rapid publication of such manuscripts - if they are submitted together with the original peer reviewer reports, letter of rejection, and a rebuttal. Please also mention this in your cover letter.

Please note that additional peer review may be necessary and the final decision will be made by the Editor.

Editorial policies

All manuscripts submitted to Antimicrobial Resistance & Infection Control should adhere to BioMed Central's editorial policies.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Citing articles in Antimicrobial Resistance & Infection Control

Articles in Antimicrobial Resistance & Infection Control  should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Antimicrob Resist Infect Control [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Antimicrob Resist Infect Control 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Appeals and complaints

Authors who wish to appeal a rejection or make a complaint should follow the procedure outlined in the BMC Editorial Policies.

Benefits of publishing with BMC

High visibility

Antimicrobial Resistance & Infection Control's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. 

Speed of publication

Antimicrobial Resistance & Infection Control offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.


Online publication in Antimicrobial Resistance & Infection Control gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Antimicrobial Resistance & Infection Control are included in article alerts and regular email updates. Some may be highlighted on Antimicrobial Resistance & Infection Control’s pages and on the BMC homepage.

In addition, articles published in Antimicrobial Resistance & Infection Control may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Antimicrobial Resistance & Infection Control. A list of articles recently press-released by journals published by BMC is available here.


As an author of an article published in Antimicrobial Resistance & Infection Control you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).

For further information about the advantages of publishing in a journal from BMC, please click here.